Clinical trials: Temporomandibular Dysfunction (TMD)
Temporomandibular Disorders
Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders
The study hypothesis was that the red (600nm) and infrared (800nm) laser therapy have the same efficacy in relieving pain and improving the quality of life of TMD patients
- Trial name
- TMD (NCT01659840)
- Testing
- Red laser, Infrared laser
- Where
- Brazil
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- Federal University of São Paulo
Temporomandibular Disorder
Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
The purpose of this proof of concept study is to evaluate the safety and efficacy of the off-label use of Aimovig® (EREN) in reducing Temporomandibular Disorder (TMD) pain compared to placebo.
- Trial name
- NCT04884763
- Testing
- Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Indiana University
Temporomandibular Disorders (TMD), Internal Derangement of the Tempromandibular Joint
Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement
This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial.
- Conditions
- Temporomandibular Disorders (TMD), Internal Derangement of the Tempromandibular Joint, Anterior Disc Displacement
- Trial name
- LPCGF in TMDs (NCT07075276)
- Testing
- Liquid Phase Concentrated Growth Factor, Conventional arthrocentesis
- Where
- Egypt
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Horus University